Aimmaxrx
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4220 Apex Hwy Ste 140, Durham, North Car...Phone Number
(919) 797-1146Website
www.aimmaxrx.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aimmaxrx
AimMax Therapeutics, Inc. is dedicated to maximizing global health through innovative scientific solutions. The company focuses on developing a product pipeline aimed at addressing various health challenges. Their services are geared towards improving health outcomes for a diverse range of clients. With a passionate team, AimMax Therapeutics is committed to advancing healthcare through research and development.Explore more
Aimmaxrx Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aimmaxrx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Aimmaxrx has new funding data
Check if Aimmaxrx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aimmaxrx launches new products
Earning: See what the market has to say on Aimmaxrx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aimmaxrx
Check out if Aimmaxrx is spiking on competitors!
Click to see if Aimmaxrx had a recent Job posting/layoffs
Aimmaxrx, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Aimmaxrx
Find 3 more new buyers
Compare Similar Companies to Aimmaxrx
Compare insights from companies similar to Aimmaxrx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aimmaxrx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aimmaxrx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aimmaxrx.
Aimmaxrx Tech Stack
A closer look at the technologies used by Aimmaxrx
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
received an award of $306,954 on May 4, 2023 by HHS NIH with an award end date of April 30, 2025. This award will support efforts focused on developing and evaluating a novel intravenous formulation of AMX-2005, a new antibiotic with potent activity against MRSA and VRE, to address high unmet needs in treating multi-drug resistant infections..
Bioengineering, Pharmaceuticals, Clinical Operations, Operations
Funding
Project
Spending/Investment
Funding
Project
Aimmaxrx News & Media
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery
TAIPEI, May 4, 2023 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (6838.TWO) and AimMax Therapeutics, Inc. (United States) announce the submission of a New Drug Application to the United States Food & Drug Administration (US FDA) for APP13007, a novel aqueous nanosuspension formulation of...Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery
TAIPEI, May 12, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838) and AimMax Therapeutics, Inc. (United States) report successful top-line results from CPN-301, the first of two pivotal Phase 3 clinical studies of APP13007, a novel ophthalmic nanosuspension formulation of a...Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting
TAIPEI, April 28, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838) and Aimmax Therapeutics, Inc. (United States) announced that results from a Phase 2 clinical study of APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension), a novel formulation of the potent...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aimmaxrx
Sign Up For FreeTo access detailed company insights
AimMax Therapeutics, Inc. is dedicated to maximizing global health through innovative scientific solutions. The company focuses on developing a product pipeline aimed at addressing various health challenges. Their services are geared towards improving health outcomes for a diverse range of clients. With a passionate team, AimMax Therapeutics is com... Read More
